Interestingly, sLex expression by carcinomas has been proposed to enhance the ability of tumor cells to metastasize to the liver through E-selectin mediated interactions [3,27,32,67] and sLex epitopes are overexpressed in liver metastases of colorectal adenocarcinomas [3,8,68]. The gene discussed is SELE; the disease is carcinoma.